Point-of-Care Diagnostics Market Analysis, Size, Development and Demand Forecast to 2020

The global point-of-care diagnostics market is witnessing growth, due to miniaturization of point-of-care testing devices, technological advancement of point-of-care devices, and healthcare decentralization. Based on product, the glucose monitoring kits segment is the largest contributor to the global point-of-care diagnostics market, due to increasing prevalence of lifestyle associated diseases, such as diabetes; whereas, the cardiac markers and infectious diseases segments are expected to grow at the fastest rate in the coming years.

Explore more about “Global Point-of-Care Diagnostics Market” at: www.psmarketresearch.com/market-analysis/point-of-care-diagnostics-market

The massive unexplored point-of-care diagnostics market in the emerging economies is creating ample opportunities for the growth of the global point-of-care diagnostics market, in the coming years. The advanced research and development activities and new product developments by the major players are supporting the demand of point-of-care devices, with better and cost effective point-of-care diagnostics, thus fuelling the growth of the global point-of-care diagnostics market.

Download TOC at: www.psmarketresearch.com/market-analysis/point-of-care-diagnostics-market/toc-sample

Some of the factors driving the growth of the global point-of-care diagnostics market are increasing prevalence of infectious diseases, increasing prevalence of hospital acquired diseases, growing government support to increase adoption of point-of-care devices, increasing usage of home based point-of-care devices, growing geriatric population, and increasing government support to increase adoption of point-of-care devices. In addition, the increasing prevalence of lifestyle associated diseases, such as cardiovascular disease and diabetes, decreasing number of technicians in central laboratories, increasing private investment for new product development, and increasing awareness campaigns and conferences are fueling the growth of the global point-of-care diagnostics market. However, the lack of alignment with definitive central lab method, drawbacks of point-of-care testing over central lab method, and strict and time consuming regulatory approval are some of the factors, restraining the growth of the global point-of-care diagnostics market to some extent. Further, the reluctance towards changing the existing treatment practice and lack of reimbursement are also hindering the growth of the global point-of-care diagnostics market.

Browse Related Market Research at: www.psmarketresearch.com/industry-report/medical-devices

The key players operating in the global point-of-care diagnostics market are Abbott Laboratories Inc., Siemens Healthcare, F Hoffmann La-Roche, Nipro Diagnostics Inc., Johnson & Johnson, Abaxis Inc., Alere Inc., Becton, Dickinson and Company, Beckman Coulter Inc., and Bayer Healthcare.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com

347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)

This release was published on openPR.